KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Return on Equity (2016 - 2025)

Rigel Pharmaceuticals (RIGL) has 15 years of Return on Equity data on record, last reported at 1.44% in Q4 2025.

  • For Q4 2025, Return on Equity rose 452.0% year-over-year to 1.44%; the TTM value through Dec 2025 reached 1.44%, up 452.0%, while the annual FY2025 figure was 1.86%, 324.0% up from the prior year.
  • Return on Equity reached 1.44% in Q4 2025 per RIGL's latest filing, up from 1.14% in the prior quarter.
  • Across five years, Return on Equity topped out at 7.02% in Q3 2022 and bottomed at 54.15% in Q2 2022.
  • Average Return on Equity over 5 years is 1.9%, with a median of 0.74% recorded in 2023.
  • Peak YoY movement for Return on Equity: tumbled -5404bps in 2022, then soared 5559bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.45% in 2021, then soared by 883bps to 3.5% in 2022, then plummeted by -76bps to 0.83% in 2023, then tumbled by -471bps to 3.08% in 2024, then surged by 147bps to 1.44% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 1.44% in Q4 2025, 1.14% in Q3 2025, and 1.95% in Q2 2025.